Search Results - "Michalopoulou, P.G."

Investigating cortical excitability and inhibition in patients with schizophrenia: A TMS-EEG study by Santoro, V., Hou, M.D., Premoli, I., Belardinelli, P., Biondi, A., Carobin, A., Puledda, F., Michalopoulou, P.G., Richardson, M.P., Rocchi, L., Shergill, S.S.

“…Transcranial magnetic stimulation (TMS) combined with electromyography (EMG) has widely been used as a non-invasive brain stimulation tool to assess…”
Get full text

Modafinil combined with cognitive training is associated with improved learning in healthy volunteers – A randomised controlled trial by Gilleen, J, Michalopoulou, P.G, Reichenberg, A, Drake, R, Wykes, T, Lewis, S.W, Kapur, S

“…Abstract Improving cognition in people with neuropsychiatric disorders remains a major clinical target. By themselves pharmacological and non-pharmacological…”
Get full text

Association of serum BDNF levels with hippocampal volumes in first psychotic episode drug-naive schizophrenic patients by Rizos, E.N, Papathanasiou, M, Michalopoulou, P.G, Mazioti, A, Douzenis, A, Kastania, A, Nikolaidou, P, Laskos, E, Vasilopoulou, K, Lykouras, L

“…Abstract Evidence suggests that hippocampal volumetric abnormalities are present in first-episode schizophrenia. The hippocampus contains the highest brain…”
Get full text

The Effects of a Combined Intervention for Cognition in Schizophrenia On Cogstate Schizophrenia Battery by Michalopoulou, P.G, Lewis, S.W, Drake, R, Reichenberg, A, Emsley, R, Kalpakidou, A.K, Lees, J, Bobin, T, Gilleen, J.K, Applegate, E, Pandina, G.J, Wykes, T, Kapur, S

“…Background Cognitive impairment in schizophrenia is a strong predictor of the functional outcome and no effective treatments are available. MATRICS Consensus…”
Get full text

Investigation of serum BDNF levels in drug-naive patients with schizophrenia by Rizos, E.N., Rontos, I., Laskos, E., Arsenis, G., Michalopoulou, P.G., Vasilopoulos, D., Gournellis, R., Lykouras, L.

“…The role of brain-derived neurotrophic factor (BDNF) is to promote and modulate the neuronal responses across neurotransmitter systems in the brain. Therefore,…”
Get full text

Association of serum brain-derived neurotrophic factor and duration of untreated psychosis in first-episode patients with schizophrenia by Rizos, E N, Michalopoulou, P G, Siafakas, N, Stefanis, N, Douzenis, A, Rontos, I, Laskos, E, Kastania, A, Zoumpourlis, V, Lykouras, L

“…The brain-derived neurotrophic factor (BDNF) levels in serum and the central nervous system are altered in patients with schizophrenia, suggesting that changes…”
Get more information

An evoked auditory response fMRI study of the effects of rTMS on putative AVH pathways in healthy volunteers by Tracy, D.K., O’Daly, O., Joyce, D.W., Michalopoulou, P.G., Basit, B.B., Dhillon, G., McLoughlin, D.M., Shergill, S.S.

“…Auditory verbal hallucinations (AVH) are the most prevalent symptom in schizophrenia. They are associated with increased activation within the temporoparietal…”
Get full text

Neuropsychological relationships in paranoid schizophrenia with and without delusional misidentification syndromes. A comparative study by Lykouras, L., Typaldou, M., Mourtzouchou, P., Oulis, P., Koutsaftis, C., Dokianaki, F., Michalopoulou, P.G., Havaki-Kontaxaki, M., Christodoulou, C.

“…Delusional misidentification syndromes (DMSs) and schizophrenia are strongly associated, since the former occur predominantly in the context of paranoid…”
Get full text